Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-Rich Plasma (PRP) therapy can promote hair growth and improve facial aesthetics, including reducing acne scars and facial burns, and it works best with three initial monthly injections.

Dermal fillers can cause hair loss, so dermatologists should be aware.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

Monthly PRP therapy is more effective than daily minoxidil for alopecia areata.

PRP injections can effectively and safely treat alopecia areata.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Acne keloidalis nuchae is a tough-to-treat condition that greatly affects quality of life, especially in men of African descent.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

The girl with autoimmune hair loss might regrow hair within a year, and treatments can help but not prevent recurrence; dermatologist referral and corticosteroids are recommended.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

No treatment alters the natural progression of alopecia areata, and effectiveness varies, with some possibly working better in children.

ATX-101 injections can cause hair loss.

Platelet-rich plasma injections significantly improved hair regrowth and thickness in patients with hair loss.

Combining triamcinolone acetonide with immunotherapy can help regrow hair in some alopecia totalis patients.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Botulinum toxin A effectively treated a man's facial cysts with no side effects and lasting results.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Orthodontic appliances can cause hair loss due to pressure.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.